CluePoints

10/06/2026

Four reasons clinical research matters.

We shared Part 1 of our ICTD reflections, personal stories from our team about why they care deeply about clinical trials. Part 2 adds a different dimension. These are voices from strategy, from loss, from hope, from oversight, from patients living the reality of underrepresented conditions.

Each one sees the work from a different angle. And each one understands something crucial: behind every protocol is a person waiting for progress.
Swipe through and hear directly from:
Young
Weiman
Stone
Farnham

Full posts linked in the comments.

09/06/2026

With PCMG Annual Assembly 2026 just one week away, we’re looking forward to an important conversation on the future of AI in clinical trials!

Richard Young will explore five defining questions shaping how our industry adopts AI, from proactive risk orchestration to evolving regulatory expectations.

As ICH E6(R3) reinforces a quality-by-design mindset and proportionate oversight, the real question isn’t whether to use AI but how to embed it responsibly, transparently, and effectively to improve human outcomes.

Berlin | June 16 | 11:30 AM –12:15 PM CEST
Join us to rethink how artificial intelligence becomes human intelligence in trial oversight.
Learn more: https://hubs.ly/Q04df8xL0

29/05/2026

CluePoints is wrapping up at the Veeva R&D and Quality Summit in Copenhagen!

This week, our team represented CluePoints at one of Europe's largest life sciences technology conferences - the Veeva R&D and Quality Summit. With 1,600+ professionals from pharma, biotech, CROs, and tech providers, we had some fantastic conversations and meaningful connections around:

✅ Risk-Based Quality Management (RBQM) & clinical operations
✅ Clinical data management, AI & automation
✅ Quality, safety & regulatory transformation
✅ Connected R&D ecosystems & unified platform strategies
✅ Operational efficiency & digital transformation

We're grateful for the great conversations and connections this week. If you want to continue the dialogue about RBQM and clinical data quality, let's stay connected.

And congratulations to our Meta AI glasses winner! 🕶️🎉

29/05/2026

CluePoints is wrapping up at the Veeva R&D and Quality Summit in Copenhagen!

This week, our team represented CluePoints at one of Europe's largest life sciences technology conferences - the Veeva R&D and Quality Summit. We had some fantastic conversations and meaningful connections around:

✅ Risk-Based Quality Management (RBQM) & clinical operations
✅ Clinical data management, AI & automation
✅ Quality, safety & regulatory transformation
✅ Connected R&D ecosystems & unified platform strategies
✅ Operational efficiency & digital transformation

A huge shoutout to Andrew Taylor, Paul MacDonald, Charlotte Byng, and Matthew Davies for representing CluePoints so well!
And congratulations to our Meta AI glasses winner! 🕶️🎉

We're grateful for the great conversations and connections this week. If you want to continue the dialogue about RBQM and clinical data quality, let's stay connected.

20/05/2026

Every vaccine. Every approved treatment. All of it was tested, proven, backed by data.

Today we celebrate International Clinical Trials Day. It started in 1747 when a Scottish surgeon named James Lind tested six treatments for scurvy. The sailors who got oranges and lemons recovered. That simple comparison became the birth of the controlled clinical trial.

Nearly 280 years later, we have statins, antiretrovirals, polio vaccines, COVID vaccines. All because people participated in trials.
But here's the challenge: fewer than 5% of eligible cancer patients enroll. 80% of trials run behind schedule due to slow enrollment. Treatments that could help people right now are stuck in development.

At CluePoints, we see this every day. That's why we exist, to help research teams run trials smarter and faster. Because when clinical trials move forward efficiently, life-changing medicines reach patients sooner.

To every researcher, monitor, sponsor, and trial participant: your work changes lives. We're here to support you.

19/05/2026

Safety oversight isn't just about catching signals, it's about connecting the dots.

We analyzed safety reporting across 2,000+ clinical studies and found that the organizations with the strongest safety cultures share one thing in common: they treat risk assessment, monitoring, triage, and action as an integrated system.

In our latest article, "Safety Reporting in RBQM: Bridging Risk Assessment, Monitoring, and Action," Sylviane and Fred dive into how leading teams approach safety in a risk-based world.

Read the full insights here:

Safety monitoring generates substantial signal volume across risk-based quality management tools, but only 30% to 36% of signals correspond to confirmed issues, suggesting the need for better prioritization, signal consolidation, and alignment between detection and proportional action.

08/05/2026

$21M Saved on a Global Phase IV Oncology Study.

A leading CRO managing a massive global Phase IV oncology study faced a choice: $40M traditional monitoring or a smarter approach.

They chose risk-based monitoring. Result: $21M in savings, stronger data quality, reduced site burden, and faster insights.

Same rigor. Half the cost.
It's not about monitoring more, it's about monitoring smarter.

Download the case study to see how: https://hubs.ly/Q04fZH8P0

08/05/2026

$21M Saved on a Global Phase IV Oncology Study.

A leading CRO managing a massive global Phase IV oncology study faced a choice: $40M traditional monitoring or a smarter approach.

They chose risk-based monitoring. Result: $21M in savings, stronger data quality, reduced site burden, and faster insights.

Same rigor. Half the cost.
It's not about monitoring more, it's about monitoring smarter.

Download the case study to see how: https://hubs.ly/Q04fZsC30

05/05/2026

CluePoints is taking the stage at SCMD EMEA and you won't want to miss this one!

Our very own Sas Maheswaran, Market Owner at CluePoints, is co-chairing a session alongside Sarah Gill, Executive Director, Clinical Monitoring, on a topic that's reshaping the way clinical trials are run.

Session: Unlocking Scientific Robustness and Operational Efficiency with RBQM
Date: May 6th
Time: 10:30am – 11:30am CET

If you're at SCMD EMEA, be sure to stop in and listen!